Neutral tumor evolution

Published on Dec 1, 2018in Nature Genetics25.455
· DOI :10.1038/s41588-018-0258-x
Maxime Tarabichi5
Estimated H-index: 5
(Francis Crick Institute),
Inigo Martincorena30
Estimated H-index: 30
(Wellcome Trust Sanger Institute)
+ 7 AuthorsPeter Van Loo48
Estimated H-index: 48
(Katholieke Universiteit Leuven)
  • References (22)
  • Citations (10)
📖 Papers frequently viewed together
233 Citations
52 Citations
9 Authors (Ruping Sun, ..., Christina Curtis)
51 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Marc J. Williams (UCL: University College London)H-Index: 6
#2Benjamin WernerH-Index: 11
Last. Trevor A. Graham (QMUL: Queen Mary University of London)H-Index: 32
view all 7 authors...
52 CitationsSource
#1Inigo Martincorena (Wellcome Trust Sanger Institute)H-Index: 30
#2Keiran Raine (Wellcome Trust Sanger Institute)H-Index: 10
Last. Peter J. Campbell (University of Cambridge)H-Index: 95
view all 9 authors...
Summary Cancer develops as a result of somatic mutation and clonal selection, but quantitative measures of selection in cancer evolution are lacking. We adapted methods from molecular evolution and applied them to 7,664 tumors across 29 cancer types. Unlike species evolution, positive selection outweighs negative selection during cancer development. On average, 10/tumor in endometrial and colorectal cancers. Half of driver substitutions occur in yet-to-be-discovered cancer genes. With increasing...
232 CitationsSource
#1David C. JohnsonH-Index: 46
#2Oleg LeniveH-Index: 4
Last. Martin KaiserH-Index: 32
view all 17 authors...
Recent studies suggest that the evolutionary history of a cancer is important in forecasting clinical outlook. To gain insight into the clonal dynamics of multiple myeloma (MM) and its possible influence on patient outcome we analysed whole exome sequencing tumor data for 333 patients from Myeloma XI, a UK phase III trial and 434 patients from the CoMMpass study, all of which had received immunomodulatory therapy (IMiD). By analysing mutant allele frequency distributions in tumors we found that ...
4 CitationsSource
#1Stefan Dentro (Francis Crick Institute)H-Index: 8
#2David C. Wedge (University of Oxford)H-Index: 45
Last. Peter Van Loo (Katholieke Universiteit Leuven)H-Index: 48
view all 3 authors...
10 CitationsSource
#1Amy J. Johnson (OSU: Ohio State University)H-Index: 54
In this issue of Blood , Erdmann et al examine the importance of phosphoinositide 3-kinase (PI3K) in diffuse large B-cell lymphoma (DLBCL) and rationalize dual inhibition of the p110 α and δ isoforms. 1
3 CitationsSource
#1Simon A. Forbes (Wellcome Trust Sanger Institute)H-Index: 35
#2David Beare (Wellcome Trust Sanger Institute)H-Index: 27
Last. Peter J. Campbell (Wellcome Trust Sanger Institute)H-Index: 95
view all 19 authors...
COSMIC, the Catalogue of Somatic Mutations in Cancer ( is a high-resolution resource for exploring targets and trends in the genetics of human cancer. Currently the broadest database of mutations in cancer, the information in COSMIC is curated by expert scientists, primarily by scrutinizing large numbers of scientific publications. Over 4 million coding mutations are described in v78 (September 2016), combining genome-wide sequencing results from 28 366 tumours with co...
744 CitationsSource
#1David T. Jones (Wellcome Trust Sanger Institute)H-Index: 85
#2Keiran Raine (Wellcome Trust Sanger Institute)H-Index: 10
Last. Peter J. Campbell (Wellcome Trust Sanger Institute)H-Index: 95
view all 8 authors...
© 2016 John Wiley & Sons, Inc. CaVEMan is an expectation maximization-based somatic substitutiondetection algorithm that is written in C. The algorithm analyzes sequence data from a test sample, such as a tumor relative to a reference normal sample from the same patient and the reference genome. It performs a comparative analysis of the tumor and normal sample to derive a probabilistic estimate for putative somatic substitutions.When combined with a set of validated post-hoc filters, CaVEMan gen...
35 CitationsSource
#1Marc J. WilliamsH-Index: 6
#2Benjamin WernerH-Index: 11
Last. Andrea SottorivaH-Index: 23
view all 5 authors...
233 CitationsSource
#1Ivana Bozic (Harvard University)H-Index: 19
#2Jeffrey M. Gerold (Harvard University)H-Index: 8
Last. Michael A. Nowak (Harvard University)H-Index: 133
view all 3 authors...
The vast majority of mutations in the exome of cancer cells are passengers, which do not affect the reproductive rate of the cell. Passengers can provide important information about the evolutionary history of an individual cancer, and serve as a molecular clock. Passengers can also become targets for immunotherapy or confer resistance to treatment. We study the stochastic expansion of a population of cancer cells describing the growth of primary tumors or metastatic lesions. We first analyze th...
57 CitationsSource
#1Noemi Andor (Stanford University)H-Index: 6
#2Trevor A. Graham (QMUL: Queen Mary University of London)H-Index: 32
Last. Carlo C. MaleyH-Index: 38
view all 8 authors...
The authors analyze the extent of intratumor heterogeneity across 12 tumor types to reveal that increased heterogeneity is a general phenomenon and has a biphasic contribution to tumor progression.
249 CitationsSource
Cited By10
#1David A. Liberles (TU: Temple University)H-Index: 31
#2Belinda S. W. Chang (U of T: University of Toronto)H-Index: 24
Last. Andrew Storfer (WSU: Washington State University)H-Index: 34
view all 10 authors...
A collection of the editors of Journal of Molecular Evolution have gotten together to pose a set of key challenges and future directions for the field of molecular evolution. Topics include challenges and new directions in prebiotic chemistry and the RNA world, reconstruction of early cellular genomes and proteins, macromolecular and functional evolution, evolutionary cell biology, genome evolution, molecular evolutionary ecology, viral phylodynamics, theoretical population genomics, somatic cel...
#1Jean Hausser (KI: Karolinska Institutet)
#2Uri Alon (Weizmann Institute of Science)H-Index: 75
Tumours vary in gene expression programmes and genetic alterations. Understanding this diversity and its biological meaning requires a theoretical framework, which could in turn guide the development of more accurate prognosis and therapy. Here, we review the theory of multi-task evolution of cancer, which is based upon the premise that tumours evolve in the host and face selection trade-offs between multiple biological functions. This theory can help identify the major biological tasks that can...
#1Yulia Rubanova (U of T: University of Toronto)H-Index: 5
#2R Shi (U of T: University of Toronto)H-Index: 1
Last. Quaid MorrisH-Index: 47
view all 9 authors...
The type and genomic context of cancer mutations depend on their causes. These causes have been characterized using signatures that represent mutation types that co-occur in the same tumours. However, it remains unclear how mutation processes change during cancer evolution due to the lack of reliable methods to reconstruct evolutionary trajectories of mutational signature activity. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole-geno...
#1Jason A. Somarelli (Duke University)H-Index: 13
#2Heather L. Gardner (Tufts University)H-Index: 6
Last. Jeffrey P. Townsend (Yale University)H-Index: 37
view all 17 authors...
#1Adriana Salcedo (OICR: Ontario Institute for Cancer Research)H-Index: 5
#2Maxime Tarabichi (Francis Crick Institute)H-Index: 5
Last. Paul C. BoutrosH-Index: 48
view all 32 authors...
Tumor DNA sequencing data can be interpreted by computational methods that analyze genomic heterogeneity to infer evolutionary dynamics. A growing number of studies have used these approaches to link cancer evolution with clinical progression and response to therapy. Although the inference of tumor phylogenies is rapidly becoming standard practice in cancer genome analyses, standards for evaluating them are lacking. To address this need, we systematically assess methods for reconstructing tumor ...
3 CitationsSource
Abstract Recently interest in multi-generational epigenetic phenomena have been fuelled by highly reproducible intergenerational and transgenerational inheritance paradigms in several model organisms. Such paradigms are essential in order to begin to use genetics to unpick the mechanistic bases of how epigenetic information may be transmitted between generations; indeed great strides have been made towards understanding these mechanisms. Far less well understood is the relationship between epige...
#2Christoffer Boström (Åbo Akademi University)H-Index: 27
Last. Thorsten B.H. Reusch (CAU: University of Kiel)H-Index: 53
view all 6 authors...
Cells in multicellular organisms are genetically heterogeneous owing to somatic mutations. The accumulation of somatic genetic variation in species undergoing asexual (or clonal) reproduction (termed modular species) may lead to phenotypic heterogeneity among modules. However, abundance and dynamics of somatic genetic variation under clonal growth, a widespread life history in nature, remain poorly understood. Here we show that branching events in a seagrass clone or genet leads to population bo...
#1Carl F. Schreck (University of California, Berkeley)H-Index: 13
#2Diana Fusco (University of California, Berkeley)H-Index: 8
Last. Oskar Hallatschek (University of California, Berkeley)H-Index: 24
view all 7 authors...
Crowding effects are key to the self-organization of densely packed cellular assemblies, such as biofilms, solid tumors, and developing tissues. When cells grow and divide they push each other apart, remodeling the structure and extent of the population9s range. It has recently been shown that crowding effects also couple the evolutionary fate of neighboring cells, thereby weakening the strength of natural selection. However, the impact of crowding on neutral processes remains unclear. Here, we ...
#1Lixing Yang (U of C: University of Chicago)H-Index: 30
#2Su Wang (Harvard University)H-Index: 8
Last. Peter J. Park (Harvard University)H-Index: 87
view all 9 authors...
The classical genetic model of colorectal cancer presents APC mutations as the earliest genomic alterations, followed by KRAS and TP53 mutations. However, the timing and relative order of clonal expansion and other types of genomic alterations, such as genomic rearrangements, are still unclear. Here, we perform comprehensive bioinformatic analysis to dissect the relative timing of somatic genetic alterations in 63 colorectal cancers with whole-genome sequencing data. Utilizing allele fractions o...